Marshall Wace participates in Areteia Therapeutics additional Series A commitment

Marshall Wace was identified as new participating investor in Areteia Therapeutics's additional Series A commitment. This was an additional commitment, not evidence of fully funded cash. The announcement identifies the financing participants; Marshall Wace’s individual investment amount and current holding are not established.